MSH|^~\&|LAB|ARH|||202003031321||ORU^R01|4179610|D|2.3|||AL|NE
PID|1||AB00007296|AB7332|LABTEST^AIR^PRESTO|||M||||||||||AB000509/19|9876146393
OBR|1|40057^LAB|00030207^0303:H00004R^LAB^030320:H4^40057|210.0000^MALARIA^Malaria Profile^^^XXX-1339||202003031317|202003031317|||||||202003031317||||||||||LAB|I||||
OBR|2|40057^LAB|00030207^0303:H00004R^LAB^030320:H4^40057|210.0550^MALNAT^Malaria NAT^^^||202003031317|202003031317|||||||202003031317||||||||||LAB|F||||
OBX|1|ST|210.0560^MALNAT R^Malaria NAT^^^|1|Positive^^N||Negative|H||A^S|F|||202003031321
NTE|1||Further testing to follow.  This assay does not distinguish
NTE|2||between residual nucleic acid (which may persist after
NTE|3||adequate treatment), and viable intact parasites. This assay
NTE|4||may detect low-grade asymptomatic parasitemia from
NTE|5||individuals exposed to malaria-endemic areas.